LMO3 and central nervous system cancer: Our previous study demonstrated the suppressor role of miR-101 in gliomas [6]; this finding is consistent with the results of the present study, which showed that the overexpression of miR-101 (Supplementary Figure S3A) inhibited the expression of LMO3 (Figure 2C and 2E) and that the knockdown of miR-101 (Supplementary Figure S3B) could enhance the expression of LMO3 in glioma cell lines (Figure 2D and 2E).